Amygdalin Exerts Antitumor Activity in Taxane-Resistant Prostate Cancer Cells

Amygdalin Exerts Antitumor Activity in Taxane-Resistant Prostate Cancer Cells

Despite recent advances in the treatment of metastatic prostate cancer (PCa), resistance development after taxane treatments is inevitable, necessitating effective options to combat drug resistance. Previous studies indicated antitumoral properties of the natural compound amygdalin. However, whether...

Full description

Bibliographic Details
Main Authors: Igor Tsaur, Anita Thomas, Michelle Monecke, Marion Zugelder, Jochen Rutz, Timothy Grein, Sebastian Maxeiner, Hui Xie, Felix K.-H. Chun, Florian Rothweiler, Jindrich Cinatl, Martin Michaelis, Axel Haferkamp, Roman A. Blaheta
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Cancers
Subjects:
prostate cancer
resistant cell lines
complementary/alternative medicine (CAM)
amygdalin
docetaxel
cabozantinib
Online Access:https://www.mdpi.com/2072-6694/14/13/3111

Internet

https://www.mdpi.com/2072-6694/14/13/3111

Similar Items